Global Diabetic Foot Ulcers and Pressure Ulcers Market: By Disease Type (Diabetic Foot Ulcers, Pressure Ulcers), By Treatment (Wound Care Dressings, Bio-actives, Wound Care Devices), By End User (Hospitals, Clinics, Home Healthcare, Community Health Centers, Others), and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024
Global diabetic foot ulcers and pressure ulcers market was valued at US $ XX Mn and expected to grow at XX% Compound Annual Growth Rate (CAGR) from 2018 to 2024.
Market Outline: Global Diabetic Foot Ulcers and Pressure Ulcers Market
Diabetic foot ulcers are the full-thickness wounds present below the ankle in diabetic patients. The risk factors for the diabetic foot ulcers include poor blood circulation, neuropathy, and insufficiently well controlled diabetes are among others. Pressure ulcers or bedsores are injuries to skin and underlying tissue, caused by the prolonged pressure on skin. Pressure ulcers are majorly affect the persons with paralysis, old age, illness, and frailty.
Market Dynamics: Global Diabetic Foot Ulcers and Pressure Ulcers Market
Increase in the prevalence diabetes and neuropathic diseases such as paralysis surge the global diabetic foot ulcers and pressure ulcers market. Moreover, rise in R&D expenditure for the innovation of newer therapeutics, government initiations to control the diabetes and chronic wounds, grow in incidence of paralysis and other chronic diseases reduces the mobility, unhealthy lifestyle, and increase in geriatric population are anticipated to propel the diabetic foot ulcers and pressure ulcers market over the forecast years. However, high cost of treatment, dearth of skilled professionals in underdeveloped countries, and limited number of biologicals for the treatment are restrain the growth of global diabetic foot ulcers and pressure ulcers market.
Market Scope: Global Diabetic Foot Ulcers and Pressure Ulcers Market
Global diabetic foot ulcers and pressure ulcers market is segmented based on disease type, treatment type, and end user
Based on disease type, market is segmented into the following:
- Diabetic Foot Ulcers
- Grade 0
- Grade 1
- Grade 2
- Grade 3
- Grade 4
- Grade 5
- Pressure Ulcers
- Stage 1
- Stage 2
- Stage 3
- Stage 4
Based on the treatment type, market is segmented into the following:
- Wound Care Dressings
- Film Dressings
- Foam Dressings
- Hydrogel Dressings
- Hydrocolloid Dressings
- Alginate Dressings
- Others
- Bio-actives
- Growth Factors
- Skin Substitute & Skin Grafts
- Others
- Wound Care Devices
- Negative Pressure Wound Therapy (NPWT)
- Ultrasound Therapy
- Others
Based on the end users, the market is segmented into the following:
- Hospitals
- Clinics
- Home Healthcare
- Community Health Canters
- Others
Regional Analysis: Global Diabetic Foot Ulcers and Pressure Ulcers Market
Geographically, global diabetic foot ulcers and pressure ulcers market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America diabetic foot ulcers and pressure ulcers market has a lucrative growth attributed to rise in prevalence of diabetic foot ulcers and pressure ulcers due to increase in the incidence of diabetes, advancements in the treatment procedures, and increase in healthcare expenditure are bolster the market. Europe diabetic foot ulcers and pressure ulcers market is poised to grow attributed to increase in the prevalence of diabetes and neurological disorders, high adoption of newer treatment procedures, and rise in disposable income are fuel the market. Asia Pacific diabetic foot ulcers and pressure ulcers market has prominent share attributed to rise in geriatric population in India, China, and Japan, large patient pool, and entry of market players into Asia Pacific region are bolster the market.
Competition Assessment: Global Diabetic Foot Ulcers and Pressure Ulcers Market
Some of the players in the global diabetic foot ulcers and pressure ulcers market include:
- Medtronic plc (Ireland)
- Braun Melsungen AG (Germany)
- Smith & Nephew plc (U.K.)
- CovaTec, Inc. (U.S.)
- Coloplast A/S (Denmark)
- Organogenesis, Inc. (U.S.)
- Medline Industries, Inc. (U.S.)
- 3M Healthcare (U.S.)
- BSN Medical GmbH (Hamburg)
- Integra Life Sciences Corporation (U.S.)
- Molnlycke Health Care AB (Sweden)
Notable Market Developments: Global Diabetic Foot Ulcers and Pressure Ulcers Market
- In January 2016, FDA approved Integra Omnigraft Dermal Regeneration Matrix to treat disabetic foot ulcers
